EFPIA - NEWSLETTER

EFPIA Newsletter 03 February 2022

News

03 February 2022 EFPIA calls for an ambitious EU approach to the challenge of NCDs

EFPIA takes note of the recently announced EU Non-Communicable Diseases (NCDs) Initiative Healthier together by the...

31 January 2022 Industry welcomes the Clinical Trials Regulation – the beginning of an exciting new phase for...

Making Europe a more attractive location for clinical research affords patients the opportunity to access the very latest...

31 January 2022 EFPIA and Vaccines Europe welcome the Regulation on a reinforced role for the European Medicines...

Strengthening the role of the EMA is an important step forward to enhance the ability of the EU to respond to health...

World Cancer Day

03 February 2022 World Cancer Day – How Can We Close the Care Gap When it Comes to Patient Access to Innovation?...

In a world where innovations are taking us closer and closer to curing cancer, we cannot afford to keep patients waiting...

02 February 2022 Committed to closing care gaps for cancer patients worldwide

A video by Dietmar Berger, Chief Medical Officer, Global Head of Development, Sanofi

Supporting Pharma Innovation in Europe

Catch-up with our latest event, organised in partnership with the FT Live. Speakers included:

Bill Anderson, CEO, Roche Pharmaceuticals
Sandra Gallina, Director General for Health and Food Safety, European Commission
Stefan Oelrich, President of Pharmaceuticals Division, Bayer AG

Moderated by Hannah Kuchler, Global Pharmaceuticals Correspondent, Financial Times

Publications

Healthier Together Initiative 2022 - Input from the EFPIA CVD Network 03 February 2022 (Publications)

Innovative thinking and political leadership is needed to change the current inertia and perception that CVD is only...

What we are reading

AMR Industry Alliance Progress Report 01 February 2022 (amrindustryalliance.org)

Commission: Pharma companies need incentives to develop orphan drugs 28 January 2022 (Euractiv)

From Innovation Mindsets To Incentives And COVID-19 Lessons: How EU Pharma Legislation Should... 27 January 2022 (Informa Pharma Intelligence)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶